Two years ago, I asked, “Doctors diagnosing addiction: Are the blind leading the blind?” The estimated rates of substance use disorder among clinical patients treated for pain vary greatly, depending on whom one believes. Studies also suffer from a widespread failure to address genetically mediated variability in minimum effective opioid dose between individuals. Thus, I
Modified DSM-5 opioid use disorder criteria for pain patients originally appeared in KevinMD.com.
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.